Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
PR Newswire
Capital Rx Appoints Antonio Garcia Cueto as Chief Financial Officer
June 18, 2024 -
PR Newswire
TraceLink MINT Awarded 2024 Supply Chain Visibility Solution of the Year by SupplyTech Breakthrough
June 13, 2024 -
Fierce Biotech
NodThera’s NLRP3 inhibitor shows further anti-inflammatory promise in phase 1b/2a obesity trial
June 12, 2024 -
PR Newswire
Benchling Builds Digital Data Foundation Powering Sanofi AI-Driven R&D
June 11, 2024 -
PR Newswire
TraceLink Partners with Genpact to Expand Delivery of Digital Supply Chain Innovation for Healthcare and Life Sciences Sectors
June 10, 2024 -
GlobeNewswire
Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
June 10, 2024 -
Prime Minister's Office of Japan
Video Message by Prime Minister Kishida at the Japan Innovation Luncheon
June 5, 2024 -
GlobeNewswire
Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology
May 30, 2024 -
PR Newswire
Stride and Roadie Partner to Empower Drivers with Financial Tools
May 29, 2024 -
PR Newswire
Paradigm and Altru Health System Expand Patient Access to Clinical Trials for Rural Population
May 29, 2024 -
Yahoo Finance
NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer
May 28, 2024 -
Business Wire
Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395
May 23, 2024 -
Atalanta Therapeutics
Atalanta Therapeutics Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer
May 22, 2024 -
PR Newswire
Expressable Raises $26M Series B to Expand Access to its Technology-Enabled Speech Therapy Solution
May 21, 2024 -
Fierce Healthcare
Centivo Acquires Eden Health to Serve Escalating Demand for Affordable, High-Quality Primary Care
May 20, 2024 -
PR Newswire
Embark Helps Dog Lovers Know Their Dog Inside and Out with Disney and Pixar’s Inside Out 2 Collaboration
May 17, 2024 -
PR Newswire
Kyruus Health Expands National Provider Network to Include Virtual Behavioral Health Services to Address Mental Health Needs in the United States
May 15, 2024 -
PR Newswire
Doceree Launches HIEP to Unveil the Untapped Potential of Healthcare Digital Platforms
May 15, 2024 -
ARTBIO
FogPharma and ARTBIO Announce Collaboration to Co-Develop Multiple Helicon™-Enabled Alpha-Particle Radioligand Therapies for the Treatment of Cancer
May 14, 2024 -
Business Wire
Ensoma Appoints Accomplished Company Builder and Product Developer, Jim Burns, Ph.D., as Chief Executive Officer
May 13, 2024 -
PR Newswire
Sturdy Health partners with Notable for improved patient experience with an AI-powered digital front door
May 13, 2024 -
PR Newswire
Affinia Therapeutics Presents Preclinical Data for Genetic Cardiomyopathy and Sporadic ALS Programs with Novel Cardiotropic and BBB-Penetrant AAV Capsids at the American Society of Gene & Cell Therapy 2024 Annual Meeting
May 10, 2024 -
MedTech Breakthrough
The 2024 MedTech Breakthrough Awards: AmplifyMD & AppliedVR
May 9, 2024 -
PR Newswire
TraceLink Named to 2024 RXinsider Pharmacy500 List
May 8, 2024 -
ARTBIO
ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials
May 7, 2024 -
PR Newswire
Adcentrx Therapeutics Announces China NMPA Grants IND Clearance for ADRX-0706, a Novel Nectin-4 ADC for the Treatment of Advanced Solid Tumors
May 6, 2024 -
TIME
TIME100 Health: Bobby Gaspar
May 3, 2024 -
Fierce Biotech
CRO GSK and Genomics collab to explore using genetics in clinical trial design
April 30, 2024 -
PR Newswire
Rippl acquires AI healthcare startup Kinto to accelerate building nation’s most advanced tech-enabled dementia care platform
April 30, 2024 -
PR Newswire
New Report Reveals that 9 out of 10 New Mothers Returning to Work Face At Least One Major Challenge That Threatens Career Success
April 30, 2024 -
PRWeb
Embark Marks Adopt a Shelter Pet Day, Wrapping Donation of 160 DNA Kits To Shelters Nationwide
April 30, 2024 -
Endpoints News
Prime Medicine receives FDA clearance to run first prime editing clinical trial
April 29, 2024 -
PR Newswire
Doceree Unlocks New Standards in HCP Engagement for Global DSP Platforms
April 24, 2024 -
PR Newswire
Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines
April 23, 2024 -
Endpoints News
Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D
April 23, 2024 -
PR Newswire
Zus Health Joins athenahealth’s Marketplace Program to Bring Real-time Clinical Data to the Point of Care
April 22, 2024 -
PR Newswire
Panasonic and Shinobi Therapeutics Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing Technology
April 18, 2024 -
Fierce Biotech
With $290M in hand, newly emerged biotech Metsera thinks customizable combos are the future of obesity treatments
April 18, 2024 -
GlobeNewswire
Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole
April 15, 2024 -
Business Wire
AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
April 15, 2024 -
Forbes
Forbes AI 50: Owkin
April 11, 2024 -
PR Newswire
Capital Rx Earns Accreditation from the National Committee for Quality Assurance (NCQA)
April 10, 2024 -
PR Newswire
Stride Launches Utah’s First Independent Worker Portable Benefits Contributions Program
April 10, 2024 -
Yahoo Finance
Genomics plc and MassMutual’s program enables more policyowners to understand health risks through innovative genetic testing
April 9, 2024 -
Endpoints News
Two ex-bluebird leaders launch Nvelop with $100M to tackle the biggest problem in gene editing
April 9, 2024 -
PR Newswire
Navigate BioPharma Services, Inc. announces collaboration with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion™ Platform
April 9, 2024 -
BioSpace
Adela Presents Data Demonstrating Ability of Tissue-Agnostic MRD Assay to Predict Recurrence in Head & Neck Cancer at the American Association for Cancer Research Annual Meeting 2024
April 8, 2024 -
PR Newswire
The Alzheimer’s Association® and Rippl Partner to Improve Quality Dementia Care and Caregiver Support
April 5, 2024 -
Elos
Eleos Health Announces Gold Tier Partnership with National Council for Mental Wellbeing Ahead of NatCon24
April 4, 2024 -
CB Insights
CB Insights AI 100: CHARM Therapeutics
April 3, 2024 -
PR Newswire
Kyruus Health Announces its Care Access Platform is Available on Google Cloud Marketplace
April 3, 2024 -
PR Newswire
Stride Launches First-Ever Independent Worker Contributions Program for Portable Benefits
April 3, 2024 -
Yahoo Finance
Protenus Granted Two New Patents for Healthcare Compliance
April 2, 2024 -
PR Newswire
Adcentrx Therapeutics to Present Preclinical Data for Nectin-4 ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 1, 2024 -
Forbes
What Change Healthcare And The Postal Service Can Tell Us About The Coming Platform Revolution
March 28, 2024 -
Forbes
It’s Healthcare’s Data Era—Finally
March 27, 2024 -
PR Newswire
Capital Rx’s Enterprise Health Platform Enables Healthcare Organizations to Meet The CENTERS for MEDICARE & MEDICAID SERVICES’ M3P Requirements
March 27, 2024 -
Yahoo Finance
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
March 26, 2024 -
Yahoo Finance
Protenus Granted Sixth Patent for Drug Diversion Surveillance Technology
March 26, 2024 -
BioCentury
Former BioMarin CEO Bienaimé named chair of Owkin
March 25, 2024 -
Owkin
Owkin expands collaboration with Sanofi leveraging AI for drug positioning in immunology
March 21, 2024 -
Fast Company
The World’s Most Innovative Companies of 2024
March 19, 2024 -
Business Wire
Almaden Genomics and Elucidata Pair g.nome® with Polly
March 19, 2024 -
BioSpace
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
March 19, 2024 -
The Economic Times
Engrail Therapeutics raises $157 million in funding from F-Prime Capital, others
March 19, 2024 -
Fast Company
This company is dispensing a dose of visibility into drug availability
March 19, 2024 -
Fierce Healthcare
Clover Health, Quartet Health team up against serious mental illness
March 19, 2024 -
Endpoints News
FDA greenlights Orchard’s gene therapy Lenmeldy for rare and fatal disease
March 18, 2024 -
Axios Pro
HiLabs inputs $39M for medical data cleanup
March 14, 2024 -
PR Newswire
Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance
March 13, 2024 -
PR Newswire
Doceree launches Spark to Ignite a New Era in Patient-Provider Engagement with Advanced Tech for EHR Platforms, at HIMSS 2024
March 12, 2024 -
Gearrice
Thanks to AI, this start-up wants to revolutionize pharmaceutical research
March 11, 2024 -
Biopharma Dive
NodThera says inflammation drug has positive effect in Parkinson’s
March 8, 2024 -
PR Newswire
OnCusp Therapeutics Announces First Patient Dosed in Phase 1 Trial of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
March 6, 2024 -
Endpoints News
Nocion Therapeutics Announces $62 Million Series B Financing to Advance Lead Program in Cough into Later Stage Development
March 4, 2024 -
AccessWire
Alcan Dental Cooperative Announces Strategic Partnership With CareStack to Enhance Dental Partnership Operations With Their Cloud-Based Dental Software Solutions
February 28, 2024 -
Goodwin
ARTBIO Collaborates with AlphaGen Therapeutics, and Enters into Three Strategic Agreements to Produce its Lead Asset AB001
February 28, 2024 -
Endpoints News
NodThera Touts Potential Weight Loss Effect of NLRP3 Inhibitors
February 20, 2024 -
ArtBio
AlphaGen Therapeutics and ARTBIO Announce Exclusive Strategic Collaboration for the Development and Commercialization of AB001 in Greater China and on ARTBIO’s 212Pb AlphaDirect™ Technology
February 20, 2024 -
PR Newswire
AppliedVR and Kernel Flow Announce Clinical Results Evaluating How Brain Changes During Virtual Reality Treatment of Chronic Pain
February 8, 2024 -
Medium
The New England Venture Capital Association Appoints Five New Directors, Kent Bennett to Board Chair
January 31, 2024 -
PR Newswire
Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System
January 31, 2024 -
Yale University
Devoret and Schoelkopf win the Comstock Prize in Physics
January 23, 2024 -
Biomarker
F-Prime: Alex Pasteur, PhD
January 22, 2024 -
PR Newswire
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
January 18, 2024 -
Eleos Health
Eleos Health Grows Behavioral Health AI Product Offerings, Expands Reach to 25 States
January 17, 2024 -
Endpoints News
Comanche secures $75M to test preeclampsia siRNA in PhII, adds Scott Gottlieb to board
January 17, 2024 -
PR Newswire
ARTBIO and PharmaLogic Announce Supply Agreement for Lead-212 based Therapeutic Candidate AB001 for New York and Surrounding States
January 12, 2024 -
Accesswire
1upHealth Reports 2023 as Record Year of Growth; Company Now Offers Largest Set of CMS APIs in the Industry
January 9, 2024 -
Financial Times
UK start-up Genomics raises £35mn for advanced genetic testing
January 8, 2024
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.